|  | C |
SECTION C — CHEMISTRY; METALLURGY

|  | C |
Note(s) In section C, the definitions of groups of chemical elements are as follows: Alkali metals: Li, Na, K, Rb, Cs, Fr Alkaline earth metals: Ca, Sr, Ba, Ra Lanthanides: elements with atomic numbers 57 to 71 inclusive Rare earths: Sc, Y, Lanthanides Actinides: elements with atomic numbers 89 to 103 inclusive Refractory metals: Ti, V, Cr, Zr, Nb, Mo, Hf, Ta, W Halogens: F, Cl, Br, I, At Noble gases: He, Ne, Ar, Kr, Xe, Rn Platinum group: Os, Ir, Pt, Ru, Rh, Pd Noble metals: Ag, Au, Platinum group Light metals: alkali metals, alkaline earth metals, Be, Al, Mg Heavy metals: metals other than light metals Iron group: Fe, Co, Ni Non-metals: H, B, C, Si, N, P, O, S, Se, Te, noble gases, halogens Metals: elements other than non-metals Transition elements: elements with atomic numbers 21 to 30 inclusive, 39 to 48 inclusive, 57 to 80 inclusive, 89 upwards Section C covers: pure chemistry, which covers inorganic compounds, organic compounds, macromolecular compounds, and their methods of preparation; applied chemistry, which covers compositions containing the above compounds, such as: glass, ceramics, fertilisers, plastics compositions, paints, products of the petroleum industry. It also covers certain compositions on account of their having particular properties rendering them suitable for certain purposes, as in the case of explosives, dyestuffs, adhesives, lubricants, and detergents; certain marginal industries, such as the manufacture of coke and of solid or gaseous fuels, the production and refining of oils, fats and waxes, the fermentation industry (e.g., brewing and wine-making), the sugar industry; certain operations or treatments, which are either purely mechanical, e.g., the mechanical treatment of leather and skins, or partly mechanical, e.g., the treatment of water or the prevention of corrosion in general; metallurgy, ferrous or non-ferrous alloys. In the case of operations, treatments, products or articles having both a chemical and a non-chemical part or aspect, the general rule is that the chemical part or aspect is covered by section C. In some of these cases, the chemical part or aspect brings with it a non-chemical one, even though purely mechanical, because this latter aspect either is essential to the operation or treatment or constitutes an important element thereof. It has seemed, in fact, more logical not to dissociate the different parts or aspects of a coherent whole. This is the case for applied chemistry and for the industries, operations and treatments mentioned in Notes (1)(c), (d) and (e). For example, furnaces peculiar to the manufacture of glass are covered by class Fulltext... Hierarchy... Expanded...C03 and not by class Fulltext... Hierarchy... Expanded...F27. There are, however, some exceptions in which the mechanical (or non-chemical) aspect carries with it the chemical aspect, for example: Certain extractive processes, in subclass Fulltext... Hierarchy... Expanded...A61K; The chemical purification of air, in subclass Fulltext... Hierarchy... Expanded...A61L; Chemical methods of fire-fighting, in subclass Fulltext... Hierarchy... Expanded...A62D; Chemical processes and apparatus, in class Fulltext... Hierarchy... Expanded...B01; Impregnation of wood, in subclass Fulltext... Hierarchy... Expanded...B27K; Chemical methods of analysis or testing, in subclass Fulltext... Hierarchy... Expanded...G01N; Photographic materials and processes, in class Fulltext... Hierarchy... Expanded...G03, and, generally, the chemical treatment of textiles and the production of cellulose or paper, in section D. In still other cases, the pure chemical aspect is covered by section C and the applied chemical aspect by another section, such as A, B or F, e.g., the use of a substance or composition for: treatment of plants or animals, covered by subclass Fulltext... Hierarchy... Expanded...A01N; foodstuffs, covered by class Fulltext... Hierarchy... Expanded...A23; ammunition or explosives, covered by class Fulltext... Hierarchy... Expanded...F42. When the chemical and mechanical aspects are so closely interlocked that a neat and simple division is not possible, or when certain mechanical processes follow as a natural or logical continuation of a chemical treatment, section C may cover, in addition to the chemical aspect, a part only of the mechanical aspect, e.g., after-treatment of artificial stone, covered by class Fulltext... Hierarchy... Expanded...C04. In this latter case, a note or a reference is usually given to make the position clear, even if sometimes the division is rather arbitrary.

CHEMISTRY

|  | C07 |
ORGANIC CHEMISTRY (such compounds as the oxides, sulfides, or oxysulfides of carbon, cyanogen, phosgene, hydrocyanic acid or salts thereof Fulltext... Hierarchy... Expanded...C01; products obtained from layered base-exchange silicates by ion-exchange with organic compounds such as ammonium, phosphonium or sulfonium compounds or by intercalation of organic compounds Fulltext... Hierarchy... Expanded...C01B 33/44; macromolecular compounds Fulltext... Hierarchy... Expanded...C08; dyes Fulltext... Hierarchy... Expanded...C09; fermentation products Fulltext... Hierarchy... Expanded...C12; fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture Fulltext... Hierarchy... Expanded...C12P; production of organic compounds by electrolysis or electrophoresis Fulltext... Hierarchy... Expanded...C25B 3/00, Fulltext... Hierarchy... Expanded...C25B 7/00) [2]

|  | C07 |
Note(s) In this class, the following term is used with the meaning indicated: "preparation" covers purification, separation, stabilisation or use of additives, unless a separate place is provided therefor. [4] Biocidal, pest repellant, pest attractant or plant growth regulatory activity of compounds or preparations is further classified in subclass Fulltext... Hierarchy... Expanded...A01P. [8] In subclasses Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...C07C-C07K and within each of theses subclasses, in the absence of an indication to the contrary, and with the exception referred to below, a compound is classified in the last appropriate place. For example, 2-butyl-pyridine, which contains an acyclic chain and a heterocyclic ring, is classified only as a heterocyclic compound, in subclass Fulltext... Hierarchy... Expanded...C07D. In general, and in the absence of an indication to the contrary (such as groups Fulltext... Hierarchy... Expanded...C07C 59/58, Fulltext... Hierarchy... Expanded...C07C 59/70), the terms "acyclic" and "aliphatic" are used to describe compounds in which there is no ring; and, if a ring were present, the compound would be taken by the "last place" rule to a later group for cycloaliphatic or aromatic compounds, if such a group exists. Where a compound or an entire group of compounds exists in tautomeric forms, it is classified as though existing in the form which is classified last in the system, unless the other form is specifically mentioned earlier in the system. Chemical compounds and their preparation are classified in the groups for the type of compound prepared. The processes of preparation are also classified in the groups for the types of reaction employed, if of interest. General processes for the preparation of a class of compounds falling into more than one main group are classified in the groups for the processes employed, when such groups exist. The compounds prepared are also classified in the groups for the types of compound prepared, if of interest. In this class, in the absence of an indication to the contrary, the compounds containing carboxyl or thiocarboxyl groups are classified as the relevant carboxylic or thiocarboxylic acids, unless the "last place rule" (see Note (3), above) dictates otherwise; a carboxyl group being a carbon atom having three bonds, and no more than three, to hetero atoms, other than nitrogen atoms of nitro or nitroso groups, with at least one multiple bond to the same hetero atom and a thiocarboxyl group being a carboxyl group having at least one bond to a sulfur atom, e.g. amides or nitriles of carboxylic acids, are classified with the corresponding acids. [5] Salts of a compound, unless specifically provided for, are classified as that compound, e.g. aniline hydrochloride is classified as containing carbon, hydrogen and nitrogen only (in group Fulltext... Hierarchy... Expanded...C07C 211/46), sodium malonate is classified as malonic acid (in Fulltext... Hierarchy... Expanded...C07C 55/08), and a mercaptide is classified as the mercaptan. Metal chelates are dealt with in the same way. Similarly, metal alcoholates and metal phenates are classified in subclass Fulltext... Hierarchy... Expanded...C07C and not in subclass Fulltext... Hierarchy... Expanded...C07F, the alcoholates in groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...C07C 31/28-C07C 31/32 and the phenates as the corresponding phenols in group Fulltext... Hierarchy... Expanded...C07C 39/235 or Fulltext... Hierarchy... Expanded...C07C 39/44. Salts, adducts or complexes formed between two or more organic compounds are classified according to all compounds forming the salts, adducts or complexes. [2]

|  | C07K |
PEPTIDES (peptides in foodstuffs Fulltext... Hierarchy... Expanded...A23, e.g. obtaining protein compositions for foodstuffs Fulltext... Hierarchy... Expanded...A23J; preparations for medicinal purposes Fulltext... Hierarchy... Expanded...A61K; peptides containing -lactam rings Fulltext... Hierarchy... Expanded...C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, Fulltext... Hierarchy... Expanded...C07D; ergot alkaloids of the cyclic peptide type Fulltext... Hierarchy... Expanded...C07D 519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific, but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids Fulltext... Hierarchy... Expanded...C08G 69/00; macromolecular products derived from proteins Fulltext... Hierarchy... Expanded...C08H 1/00; preparation of glue or gelatine Fulltext... Hierarchy... Expanded...C09H; single cell proteins, enzymes Fulltext... Hierarchy... Expanded...C12N; genetic engineering processes for obtaining peptides Fulltext... Hierarchy... Expanded...C12N 15/00; compositions for measuring or testing processes involving enzymes Fulltext... Hierarchy... Expanded...C12Q; investigation or analysis of biological material Fulltext... Hierarchy... Expanded...G01N 33/00) [4]

|  | C07K |
Note(s) In this subclass, the following terms or expressions are used with the meanings indicated: "amino acids" are compounds in which at least one amino group and at least one carboxyl group are bound to the same carbon skeleton and the nitrogen atom of the amino group may form part of a ring; "normal peptide link" is one between an alpha-amino group of an amino acid and the carboxyl group — in position 1 — of another alpha-amino acid; "abnormal peptide link" is a link where at least one of the linked amino acids is not an alpha-amino acid or a link formed by at least one carboxyl or amino group being part of the side chain of an alpha-amino acid; "peptides" are compounds containing at least two amino acid units, which are bound through at least one normal peptide link, including oligopeptides, polypeptides and proteins, where "linear peptides" may comprise rings formed through S—S bridges, or through an hydroxy or a mercapto group of an hydroxy- or a mercapto-amino acid and the carboxyl group of another amino acid (e.g. peptide lactones) but do not comprise rings which are formed only through peptide links; "cyclic peptides" are peptides comprising at least one ring formed only through peptide links; the cyclisation may occur only through normal peptide links or through abnormal peptide links, e.g. through the 4-amino group of 2,4-diamino-butanoic acid. Thus, cyclic compounds in which at least one link in the ring is a non-peptide link are considered as "linear peptides"; "depsipeptides" are compounds containing a sequence of at least two alpha-amino acids and at least one alpha-hydroxy carboxylic acid, which are bound through at least one normal peptide link and ester links, derived from the hydroxy carboxylic acids, where "linear depsipeptides" may comprise rings formed through S—S bridges, or through an hydroxy or a mercapto group of an hydroxy-, or mercapto-amino acid and the carboxyl group of another amino- or hydroxy-acid but do not comprise rings formed only through peptide or ester links derived from hydroxy carboxylic acids, e.g. Gly-Ala-Gly—OCH2CO2H and Gly—OCH2CO-Ala-Gly are considered as "linear depsipeptides", but HOCH2CO-Gly-Ala-Gly does not contain an ester link, and is thus a derivative of Gly-Ala-Gly which is covered by Fulltext... Hierarchy... Expanded...C07K 5/08; "cyclic depsipeptides" are peptides containing at least one ring formed only through peptide or ester links — derived from hydroxy carboxylic acids —, e.g. ; [4] "hybrid peptides" are peptides produced through fusion or covalent binding of two or more heterologous peptides. Attention is drawn to Note (3) after class Fulltext... Hierarchy... Expanded...C07, which defines the last place priority rule applied in the range of subclasses Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...C07C-C07K and within these subclasses. [8] Therapeutic activity of compounds is further classified in subclass Fulltext... Hierarchy... Expanded...A61P. [7] When classifying in this subclass, classification is also made in group Fulltext... Hierarchy... Expanded...B01D 15/08 insofar as subject matter of general interest relating to chromatography is concerned. [8] Fragments of peptides or peptides modified by removal or addition of amino acids, by substitution of amino acids by others, or by combination of these modifications are classified as the parent peptides. However, fragments of peptides having only four or less amino acids are also classified in group Fulltext... Hierarchy... Expanded...C07K 5/00. [6] Peptides prepared by chemical processes and having an amino acid sequence derived from naturally occurring peptides are classified with the natural one. [6] Peptides prepared by recombinant DNA technology are not classified according to the host, but according to the original peptide expressed, e.g. HIV peptide expressed in E. coli is classified with HIV peptides. [6]

|  | C07K |
Subclass index
PEPTIDES |
Preparation | 1/00
of undefined number of amino acids | 2/00
Having up to 20 amino acids in an undefined or only partially defined sequence | 4/00
Having up to 20 amino acids in a fully defined sequence | 5/00 - 9/00
Depsipeptides having up to 20 amino acids in a fully defined sequence | 11/00
Having more than 20 amino acids | 14/00
Immunoglobulins | 16/00
Carrier-bound or immobilised peptides | 17/00
Hybrid peptides | 19/00

P:100 |  | C07K 1/00 |
General processes for the preparation of peptides [4]

|  | C07K 1/02 |
· | in solution [4]

|  | C07K 1/04 |
· | on carriers [4]

|  | C07K 1/06 |
· | using protecting groups or activating agents [4]

|  | C07K 1/08 |
· · | using activating agents [4]

|  | C07K 1/10 |
· | using coupling agents [4]

|  | C07K 1/107 |
· | by chemical modification of precursor peptides [6]

|  | C07K 1/113 |
· · | without change of the primary structure [6]

|  | C07K 1/12 |
· | by hydrolysis [4]

|  | C07K 1/13 |
· | Labelling of peptides [6]

|  | C07K 1/14 |
· | Extraction; Separation; Purification [4,6]

|  | C07K 1/16 |
· · | by chromatography [6]

|  | C07K 1/18 |
· · · | Ion-exchange chromatography [6]

|  | C07K 1/20 |
· · · | Partition-, reverse-phase or hydrophobic interaction chromatography [6]

|  | C07K 1/22 |
· · · | Affinity chromatography or related techniques based upon selective absorption processes [6]

|  | C07K 1/24 |
· · | by electrochemical means [6]

|  | C07K 1/26 |
· · · | Electrophoresis [6]

|  | C07K 1/28 |
· · · · | Isoelectric focusing [6]

|  | C07K 1/30 |
· · | by precipitation [6]

|  | C07K 1/32 |
· · · | as complexes [6]

|  | C07K 1/34 |
· · | by filtration, ultrafiltration or reverse osmosis [6]

|  | C07K 1/36 |
· · | by a combination of two or more processes of different types [6]

P:90 |  | C07K 2/00 |
Peptides of undefined number of amino acids; Derivatives thereof [6]

P:80 |  | C07K 4/00 |
Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof [6]

|  | C07K 4/02 |
· | from viruses [6]

|  | C07K 4/04 |
· | from bacteria [6]

|  | C07K 4/06 |
· | from fungi [6]

|  | C07K 4/08 |
· | from algae; from lichens [6]

|  | C07K 4/10 |
· | from plants [6]

|  | C07K 4/12 |
· | from animals; from humans [6]

P:70 |  | C07K 5/00 |
Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof [4]

|  | C07K 5/00 |
Note(s) In this group, the following expression is used with the meaning indicated: [6] "first amino acid" means the first amino acid from the left side, i.e. the N-terminal amino acid, of the peptide sequence. [6]

|  | C07K 5/02 |
· | containing at least one abnormal peptide link [4]

|  | C07K 5/023 |
· · | in which at least a beta-amino acid is involved [6]

|  | C07K 5/027 |
· · | in which at least a gamma-amino acid is involved, e.g. statine [6]

|  | C07K 5/03 |
· · | in which at least a delta-amino acid is involved, e.g. isosteres [6]

|  | C07K 5/033 |
· · | in which at least an epsilon- or zeta-amino acid is involved [6]

|  | C07K 5/037 |
· · | the abnormal link being formed by the side chain of an alpha-amino acid, e.g. gamma-Glu, epsilon-Lys, glutathione [6]

|  | C07K 5/04 |
· | containing only normal peptide links [4]

|  | C07K 5/06 |
· · | Dipeptides [4]

|  | C07K 5/062 |
· · · | the side chain of the first amino acid being acyclic, e.g. Gly, Ala [6]

|  | C07K 5/065 |
· · · | the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr [6]

|  | C07K 5/068 |
· · · | the side chain of the first amino acid containing more amino groups than carboxyl groups, or derivatives thereof, e.g. Lys, Arg [6]

|  | C07K 5/072 |
· · · | the side chain of the first amino acid containing more carboxyl groups than amino groups, or derivatives thereof, e.g. Asp, Glu, Asn [6]

|  | C07K 5/075 |
· · · · | Asp-Phe; Derivatives thereof, e.g. aspartame [6]

|  | C07K 5/078 |
· · · | the first amino acid being heterocyclic, e.g. Pro, His, Trp [6]

|  | C07K 5/08 |
· · | Tripeptides [4]

|  | C07K 5/083 |
· · · | the side chain of the first amino acid being acyclic, e.g. Gly, Ala [6]

|  | C07K 5/087 |
· · · | the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr [6]

|  | C07K 5/09 |
· · · | the side chain of the first amino acid containing more amino groups than carboxyl groups, or derivatives thereof, e.g. Lys, Arg [6]

|  | C07K 5/093 |
· · · | the side chain of the first amino acid containing more carboxyl groups than amino groups, or derivatives thereof, e.g. Asp, Glu, Asn [6]

|  | C07K 5/097 |
· · · | the first amino acid being heterocyclic, e.g. Pro, His, Trp, e.g. thyroliberin, melanostatin [6]

|  | C07K 5/10 |
· · | Tetrapeptides [4]

|  | C07K 5/103 |
· · · | the side chain of the first amino acid being acyclic, e.g. Gly, Ala [6]

|  | C07K 5/107 |
· · · | the side chain of the first amino acid containing carbocyclic rings, e.g. Phe, Tyr [6]

|  | C07K 5/11 |
· · · | the side chain of the first amino acid containing more amino groups than carboxyl groups, or derivatives thereof, e.g. Lys, Arg [6]

|  | C07K 5/113 |
· · · | the side chain of the first amino acid containing more carboxyl groups than amino groups, or derivatives thereof, e.g. Asp, Glu, Asn [6]

|  | C07K 5/117 |
· · · | the first amino acid being heterocyclic, e.g. Pro, His, Trp [6]

|  | C07K 5/12 |
· · | Cyclic peptides [4]

P:60 |  | C07K 7/00 |
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof [4,6]

|  | C07K 7/02 |
· | Linear peptides containing at least one abnormal peptide link [4]

|  | C07K 7/04 |
· | Linear peptides containing only normal peptide links [4]

|  | C07K 7/06 |
· · | having 5 to 11 amino acids [4]

|  | C07K 7/08 |
· · | having 12 to 20 amino acids (gastrins Fulltext... Hierarchy... Expanded...C07K 14/595; somatostatins Fulltext... Hierarchy... Expanded...C07K 14/655; melanotropins Fulltext... Hierarchy... Expanded...C07K 14/68) [4,6]

|  | C07K 7/14 |
· · | Angiotensins; Related peptides [4]

|  | C07K 7/16 |
· · | Oxytocins; Vasopressins; Related peptides [4]

|  | C07K 7/18 |
· · | Kallidins; Bradykinins; Related peptides [4]

|  | C07K 7/22 |
· · | Eledoisins; Related peptides [4]

|  | C07K 7/23 |
· · | Luteinising hormone-releasing hormone (LHRH); Related peptides [6]

|  | C07K 7/28 |
· · | Gramicidins A, B, D; Related peptides [4]

|  | C07K 7/50 |
· | Cyclic peptides containing at least one abnormal peptide link [4]

|  | C07K 7/52 |
· · | with only normal peptide links in the ring [4]

|  | C07K 7/54 |
· · | with at least one abnormal peptide link in the ring [4]

|  | C07K 7/56 |
· · · | the cyclisation not occurring through 2,4-diamino-butanoic acid [4]

|  | C07K 7/58 |
· · · · | Bacitracins; Related peptides [4]

|  | C07K 7/60 |
· · · | the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid [4]

|  | C07K 7/62 |
· · · · | Polymyxins; Related peptides [4]

|  | C07K 7/64 |
· | Cyclic peptides containing only normal peptide links [4]

|  | C07K 7/66 |
· · | Gramicidins S, C; Tyrocidins A, B, C; Related peptides [4]

P:50 |  | C07K 9/00 |
Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof [4,6]

P:40 |  | C07K 11/00 |
Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof [4,6]

|  | C07K 11/02 |
· | cyclic, e.g. valinomycins [4]

P:30 |  | C07K 14/00 |
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof [6]

|  | C07K 14/005 |
· | from viruses [6]

|  | C07K 14/01 |
· · | DNA viruses [6]

|  | C07K 14/015 |
· · · | Parvoviridae, e.g. feline panleukopenia virus, human parvovirus [6]

|  | C07K 14/02 |
· · · | Hepadnaviridae, e.g. hepatitis B virus [6]

|  | C07K 14/025 |
· · · | Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus [6]

|  | C07K 14/03 |
· · · | Herpetoviridae, e.g. pseudorabies virus [6]

|  | C07K 14/035 |
· · · · | Herpes simplex virus I or II [6]

|  | C07K 14/04 |
· · · · | Varicella-zoster virus [6]

|  | C07K 14/045 |
· · · · | Cytomegalovirus [6]

|  | C07K 14/05 |
· · · · | Epstein-Barr virus [6]

|  | C07K 14/055 |
· · · · | Marek's disease virus [6]

|  | C07K 14/06 |
· · · · | Infectious bovine rhinotracheitis virus [6]

|  | C07K 14/065 |
· · · | Poxviridae, e.g. avipoxvirus [6]

|  | C07K 14/07 |
· · · · | Vaccinia virus; Variola virus [6]

|  | C07K 14/075 |
· · · | Adenoviridae [6]

|  | C07K 14/08 |
· · | RNA viruses [6]

|  | C07K 14/085 |
· · · | Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus [6]

|  | C07K 14/09 |
· · · · | Foot-and-mouth disease virus [6]

|  | C07K 14/095 |
· · · · | Rhinovirus [6]

|  | C07K 14/10 |
· · · · | Hepatitis A virus [6]

|  | C07K 14/105 |
· · · · | Poliovirus [6]

|  | C07K 14/11 |
· · · | Orthomyxoviridae, e.g. influenza virus [6]

|  | C07K 14/115 |
· · · | Paramyxoviridae, e.g. parainfluenza virus [6]

|  | C07K 14/12 |
· · · · | Mumps virus; Measles virus [6]

|  | C07K 14/125 |
· · · · | Newcastle disease virus [6]

|  | C07K 14/13 |
· · · · | Canine distemper virus [6]

|  | C07K 14/135 |
· · · · | Respiratory syncytial virus [6]

|  | C07K 14/14 |
· · · | Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus [6]

|  | C07K 14/145 |
· · · | Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokda virus, vesicular stomatitis virus [6]

|  | C07K 14/15 |
· · · | Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus [6]

|  | C07K 14/155 |
· · · · | Lentiviridae, e.g. human immunodeficiency virus (HIV), visna-maedi virus, equine infectious anaemia virus [6]

|  | C07K 14/16 |
· · · · · | HIV-1 [6]

|  | C07K 14/165 |
· · · | Coronaviridae, e.g. avian infectious bronchitis virus [6]

|  | C07K 14/17 |
· · · · | Porcine transmissible gastroenteritis virus [6]

|  | C07K 14/175 |
· · · | Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus [6]

|  | C07K 14/18 |
· · · | Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus [6]

|  | C07K 14/185 |
· · · · | Hog cholera virus [6]

|  | C07K 14/19 |
· · · · | Rubella virus [6]

|  | C07K 14/195 |
· | from bacteria [6]

|  | C07K 14/20 - C07K 14/365 |
Note(s) In groups Fulltext... Hierarchy... Expanded...Fulltext... Hierarchy... Expanded...C07K 14/20-C07K 14/365, where appropriate, after the bacteria terminology, the indication of the order (O), family (F) or genus (G) of the bacteria is given in brackets. [6]

|  | C07K 14/20 |
· · | from Spirochaetales (O), e.g. Treponema, Leptospira [6]

|  | C07K 14/205 |
· · | from Campylobacter (G) [6]

|  | C07K 14/21 |
· · | from Pseudomonadaceae (F) [6]

|  | C07K 14/215 |
· · | from Halobacteriaceae (F) [6]

|  | C07K 14/22 |
· · | from Neisseriaceae (F), e.g. Acinetobacter [6]

|  | C07K 14/225 |
· · | from Alcaligenes (G) [6]

|  | C07K 14/23 |
· · | from Brucella (G) [6]

|  | C07K 14/235 |
· · | from Bordetella (G) [6]

|  | C07K 14/24 |
· · | from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia [6]

|  | C07K 14/245 |
· · · | Escherichia (G) [6]

|  | C07K 14/25 |
· · · | Shigella (G) [6]

|  | C07K 14/255 |
· · · | Salmonella (G) [6]

|  | C07K 14/26 |
· · · | Klebsiella (G) [6]

|  | C07K 14/265 |
· · · | Enterobacter (G) [6]

|  | C07K 14/27 |
· · · | Erwinia (G) [6]

|  | C07K 14/275 |
· · · | Hafnia (G) [6]

|  | C07K 14/28 |
· · | from Vibrionaceae (F) [6]

|  | C07K 14/285 |
· · | from Pasteurellaceae (F), e.g. Haemophilus influenza [6]

|  | C07K 14/29 |
· · | from Richettsiales (O) [6]

|  | C07K 14/295 |
· · | from Chlamydiales (O) [6]

|  | C07K 14/30 |
· · | from Mycoplasmatales, e.g. Pleuropneumonia-like organisms (PPLO) [6]

|  | C07K 14/305 |
· · | from Micrococcaceae (F) [6]

|  | C07K 14/31 |
· · · | from Staphylococcus (G) [6]

|  | C07K 14/315 |
· · | from Streptococcus (G), e.g. Enterococci [6]

|  | C07K 14/32 |
· · | from Bacillus (G) [6]

|  | C07K 14/325 |
· · · | Bacillus thuringiensis crystal peptide (delta-endotoxin) [6]

|  | C07K 14/33 |
· · | from Clostridium (G) [6]

|  | C07K 14/335 |
· · | from Lactobacillus (G) [6]

|  | C07K 14/34 |
· · | from Corynebacterium (G) [6]

|  | C07K 14/345 |
· · | from Brevibacterium (G) [6]

|  | C07K 14/35 |
· · | from Mycobacteriaceae (F) [6]

|  | C07K 14/355 |
· · | from Nocardia (G) [6]

|  | C07K 14/36 |
· · | from Actinomyces; from Streptomyces (G) [6]

|  | C07K 14/365 |
· · | from Actinoplanes (G) [6]

|  | C07K 14/37 |
· | from fungi [6]

|  | C07K 14/375 |
· · | from Basidiomycetes [6]

|  | C07K 14/38 |
· · | from Aspergillus [6]

|  | C07K 14/385 |
· · | from Penicillium [6]

|  | C07K 14/39 |
· · | from yeasts [6]

|  | C07K 14/395 |
· · · | from Saccharomyces [6]

|  | C07K 14/40 |
· · · | from Candida [6]

|  | C07K 14/405 |
· | from algae [6]

|  | C07K 14/41 |
· | from lichens [6]

|  | C07K 14/415 |
· | from plants [6]

|  | C07K 14/42 |
· · | Lectins, e.g. concanavalin, phytohaemagglutinin [6]

|  | C07K 14/425 |
· · | Zeins [6]

|  | C07K 14/43 |
· · | Thaumatin [6]

|  | C07K 14/435 |
· | from animals; from humans [6]

|  | C07K 14/44 |
· · | from protozoa [6]

|  | C07K 14/445 |
· · · | Plasmodium [6]

|  | C07K 14/45 |
· · · | Toxoplasma [6]

|  | C07K 14/455 |
· · · | Eimeria [6]

|  | C07K 14/46 |
· · | from vertebrates [6]

|  | C07K 14/465 |
· · · | from birds [6]

|  | C07K 14/47 |
· · · | from mammals [6]

|  | C07K 14/475 |
· · | Growth factors; Growth regulators [6]

|  | C07K 14/48 |
· · · | Nerve growth factor (NGF) [6]

|  | C07K 14/485 |
· · · | Epidermal growth factor (EGF) (urogastrone) [6]

|  | C07K 14/49 |
· · · | Platelet-derived growth factor (PDGF) [6]

|  | C07K 14/495 |
· · · | Transforming growth factor (TGF) [6]

|  | C07K 14/50 |
· · · | Fibroblast growth factor (FGF) [6]

|  | C07K 14/505 |
· · · | Erythropoietin (EPO) [6]

|  | C07K 14/51 |
· · · | Bone morphogenic factor; Osteogenin; Osteogenic factor; Bone-inducing factor [6]

|  | C07K 14/515 |
· · · | Angiogenic factor; Angiogenin [6]

|  | C07K 14/52 |
· · | Cytokines; Lymphokines; Interferons [6]

|  | C07K 14/525 |
· · · | Tumour necrosis factor (TNF) [6]

|  | C07K 14/53 |
· · · | Colony-stimulating factor (CSF) [6]

|  | C07K 14/535 |
· · · · | Granulocyte CSF; Granulocyte-macrophage CSF [6]

|  | C07K 14/54 |
· · · | Interleukins (IL) [6]

|  | C07K 14/545 |
· · · · | IL-1 [6]

|  | C07K 14/55 |
· · · · | IL-2 [6]

|  | C07K 14/555 |
· · · | Interferons (IFN) [6]

|  | C07K 14/56 |
· · · · | IFN-alpha [6]

|  | C07K 14/565 |
· · · · | IFN-beta [6]

|  | C07K 14/57 |
· · · · | IFN-gamma [6]

|  | C07K 14/575 |
· · | Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin Fulltext... Hierarchy... Expanded...C07K 14/665, e.g. corticotropin Fulltext... Hierarchy... Expanded...C07K 14/695) [6]

|  | C07K 14/58 |
· · · | Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide (ANP); Cardionatrin; Cardiodilatin [6]

|  | C07K 14/585 |
· · · | Calcitonins [6]

|  | C07K 14/59 |
· · · | Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH) [6]

|  | C07K 14/595 |
· · · | Gastrins; Cholecystokinins (CCK) [6]

|  | C07K 14/60 |
· · · | Growth hormone-releasing factor (GH-RF) (Somatoliberin) [6]

|  | C07K 14/605 |
· · · | Glucagons [6]

|  | C07K 14/61 |
· · · | Growth hormone (GH) (Somatotropin) [6]

|  | C07K 14/615 |
· · · · | Extraction from natural sources [6]

|  | C07K 14/62 |
· · · | Insulins [6]

|  | C07K 14/625 |
· · · · | Extraction from natural sources [6]

|  | C07K 14/63 |
· · · | Motilins [6]

|  | C07K 14/635 |
· · · | Parathyroid hormone (parathormone); Parathyroid hormone-related peptides [6]

|  | C07K 14/64 |
· · · | Relaxins [6]

|  | C07K 14/645 |
· · · | Secretins [6]

|  | C07K 14/65 |
· · · | Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2 [6]

|  | C07K 14/655 |
· · · | Somatostatins [6]

|  | C07K 14/66 |
· · · | Thymopoietins [6]

|  | C07K 14/665 |
· · | derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin [6]

|  | C07K 14/67 |
· · · | Lipotropins, e.g. beta- or gamma-lipotropin [6]

|  | C07K 14/675 |
· · · | Beta-endorphins [6]

|  | C07K 14/68 |
· · · | Melanocyte-stimulating hormone (MSH) [6]

|  | C07K 14/685 |
· · · · | Alpha-melanotropin [6]

|  | C07K 14/69 |
· · · · | Beta-melanotropin [6]

|  | C07K 14/695 |
· · · | Corticotropin (ACTH) [6]

|  | C07K 14/70 |
· · · | Enkephalins [6]

|  | C07K 14/705 |
· · | Receptors; Cell surface antigens; Cell surface determinants [6]

|  | C07K 14/71 |
· · · | for growth factors; for growth regulators [6]

|  | C07K 14/715 |
· · · | for cytokines; for lymphokines; for interferons [6]

|  | C07K 14/72 |
· · · | for hormones [6]

|  | C07K 14/725 |
· · · | T-cell receptors [6]

|  | C07K 14/73 |
· · · · | CD4 [6]

|  | C07K 14/735 |
· · · | Fc receptors [6]

|  | C07K 14/74 |
· · · | Major histocompatibility complex (MHC) [6]

|  | C07K 14/745 |
· · | Blood coagulation or fibrinolysis factors [6]

|  | C07K 14/75 |
· · · | Fibrinogen [6]

|  | C07K 14/755 |
· · · | Factors VIII [6]

|  | C07K 14/76 |
· · | Albumins [6]

|  | C07K 14/765 |
· · · | Serum albumin, e.g. HSA [6]

|  | C07K 14/77 |
· · · | Ovalbumin [6]

|  | C07K 14/775 |
· · | Apolipopeptides [6]

|  | C07K 14/78 |
· · | Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG) [6]

|  | C07K 14/785 |
· · | Alveolar surfactant peptides; Pulmonary surfactant peptides [6]

|  | C07K 14/79 |
· · | Transferrins, e.g. lactoferrins, ovotransferrins [6]

|  | C07K 14/795 |
· | Porphyrin- or corrin-ring-containing peptides [6]

|  | C07K 14/80 |
· · | Cytochromes [6]

|  | C07K 14/805 |
· · | Haemoglobins; Myoglobins [6]

|  | C07K 14/81 |
· | Protease inhibitors [6]

|  | C07K 14/815 |
· · | from leeches, e.g. hirudin, eglin [6]

|  | C07K 14/82 |
· | Translation products from oncogenes [6]

|  | C07K 14/825 |
· | Metallothioneins [6]

P:20 |  | C07K 16/00 |
Immunoglobulins, e.g. monoclonal or polyclonal antibodies [6]

|  | C07K 16/02 |
· | from eggs [6]

|  | C07K 16/04 |
· | from milk [6]

|  | C07K 16/06 |
· | from serum [6]

|  | C07K 16/08 |
· | against material from viruses [6]

|  | C07K 16/10 |
· · | from RNA viruses [6]

|  | C07K 16/12 |
· | against material from bacteria [6]

|  | C07K 16/14 |
· | against material from fungi, algae or lichens [6]

|  | C07K 16/16 |
· | against material from plants [6]

|  | C07K 16/18 |
· | against material from animals or humans [6]

|  | C07K 16/20 |
· · | from protozoa [6]

|  | C07K 16/22 |
· · | against growth factors [6]

|  | C07K 16/24 |
· · | against cytokines, lymphokines or interferons [6]

|  | C07K 16/26 |
· · | against hormones [6]

|  | C07K 16/28 |
· · | against receptors, cell surface antigens or cell surface determinants [6]

|  | C07K 16/30 |
· · · | from tumour cells [6]

|  | C07K 16/32 |
· · | against translation products from oncogenes [6]

|  | C07K 16/34 |
· · | against blood group antigens [6]

|  | C07K 16/36 |
· · | against blood coagulation factors [6]

|  | C07K 16/38 |
· | against protease inhibitors of peptide structure [6]

|  | C07K 16/40 |
· | against enzymes [6]

|  | C07K 16/42 |
· | against immunoglobulins (anti-idiotypic antibodies) [6]

|  | C07K 16/44 |
· | against material not provided for elsewhere [6]

|  | C07K 16/46 |
· | Hybrid immunoglobulins (hybrids of an immunoglobulin with a peptide not being an immunoglobulin Fulltext... Hierarchy... Expanded...C07K 19/00) [6]

P:10 |  | C07K 17/00 |
Carrier-bound or immobilised peptides (carrier-bound or immobilised enzymes Fulltext... Hierarchy... Expanded...C12N 11/00); Preparation thereof [4]

|  | C07K 17/02 |
· | Peptides being immobilised on, or in, an organic carrier [4]

|  | C07K 17/04 |
· · | entrapped within the carrier, e.g. gel, hollow fibre [4]

|  | C07K 17/06 |
· · | attached to the carrier via a bridging agent [4]

|  | C07K 17/08 |
· · | the carrier being a synthetic polymer [4]

|  | C07K 17/10 |
· · | the carrier being a carbohydrate [4]

|  | C07K 17/12 |
· · · | Cellulose or derivatives thereof [4]

|  | C07K 17/14 |
· | Peptides being immobilised on, or in, an inorganic carrier [4]

P:0 |  | C07K 19/00 |
Hybrid peptides [6]